Neurodevelopmental Dimensional Assessment and Genomic Risk of Neuropsychiatric Conditions

Association for Child and Adolescent Mental Health (ACAMH)

DOI: 10.13056/acamh.25584
In this Papers Podcast, Dr. Sam Chawner discusses his JCPP Advances paper ‘Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions’ (https://doi.org/10.1002/jcv2.12162). Sam is the first author of the paper.
There is an overview of the paper, methodology, key findings, and implications for practice.
Discussion points include:

• What are copy-number variants (CNVs) and how they impact child development.
• Insight into what 22q11.2 deletion syndrome is, how it is typically diagnosed, and how it is associated with psychiatric risk.
• Implications for clinicians and CAMH professionals.
• Whether there are adequate interventions targeted at early age groups.
• Recommendations for prevention, detection, and the targeting of interventions.

In this series, we speak to authors of papers published in one of ACAMH’s three journals. These are The Journal of Child Psychology and Psychiatry (JCPP); The Child and Adolescent Mental Health (CAMH) journal; and JCPP Advances.